In early EPCs, CD45 mRNA levels were significantly higher in the CAD patient group than in the control group (p < 0.05); however, CD31 and KDR mRNA levels tended to be higher in the control group than in the CAD patient group (Figure 4). This evidence concerns the gene PTPRC and coronary artery disorder.